Conrad Russell Y. Cruz, MD, PhD
- Principal Investigator, Program for Cell Enhancement and Technologies for Immunotherapies (CETI)
Contact
- Conrad Russell Y. Cruz, MD, PhD
- [email protected]
- 202-476-2046
Research Center Memberships
Research Interests
- Program for Cell Enhancement and Technologies for Immunotherapy
- Immune cell therapy for cancer and opportunistic infections
-
- PhD, Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, (2012)
- MD, Medicine, University of the Philippines, Manila, Philippines, (2003)
- BS, Molecular Biology and Biotechnology, University of the Philippines, Quezon City, Philippines, (1998)
-
Associate Professor of Pediatrics - George Washington University School of Medicine and Health Sciences
Associate Professor of Microbiology, Immunology, and Tropical Medicine - George Washington University School of Medicine and Health Sciences
-
-
- Innovation District
What’s a TAA-T? Advocates create videos to translate science for patients
-
- Innovation District
Catherine Bollard, M.D., M.B.Ch.B., selected to lead global Cancer Grand Challenges team
-
- Innovation District
Children’s National Hospital scientists shortlisted for Cancer Grand Challenges funding
-
- Innovation District
PRAME-specific T cell product may facilitate rapid treatment in cancer settings
-
- Innovation District
Children’s National spin-out cell therapy company receives funding
-
- News
STAT: Here are the contenders for STAT Madness 2020. Voting begins March 2
-
Contact
- Conrad Russell Y. Cruz, MD, PhD
- [email protected]
- 202-476-2046
Research Center Memberships
Research Interests
- Program for Cell Enhancement and Technologies for Immunotherapy
- Immune cell therapy for cancer and opportunistic infections